A renaissance in peptide-based pharmaceuticals has occurred recently as new technologies have emerged to make peptides more viable as drug candidates. According to the Peptide Therapeutics Foundation ( the number of new peptides entering the clinic doubled in the past decade, and four US-approved peptides have achieved global sales over the $1 billion benchmark. To date, 54 therapeutic peptides have been approved worldwide, including 26 drugs in the US.

JT Pharmaceuticals mission is to use our proprietary peptide modification technology to convert bioactive peptides into novel drug entities.

The Peptide Advantage The JT Pharma Advantage

The Company

JT Pharmaceuticals Inc. (JT Pharma) is a peptide drug development company, focused on creating new drugs for acute, medically underserved, indications. We are based in the Charleston SC area, which is rapidly developing a nucleus of novel biotechnology companies, and is primed for further expansion. In addition, the Charleston area routinely appears on surveys of the best places to live or vacation in the United States.

Learn More

Contact Us

Contact Info

Mr. James R. McNab, Jr.
Chairman and CEO

JT Pharmaceuticals, Inc.
300 West Coleman Blvd., Suite 203
Mt. Pleasant, SC 29464